Suppr超能文献

相似文献

1
Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers.
Neurology. 2011 Apr 19;76(16):1383-8. doi: 10.1212/WNL.0b013e3182167147.
2
Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes.
Neurology. 2011 Mar 22;76(12):1078-84. doi: 10.1212/WNL.0b013e318211c3ae. Epub 2011 Feb 16.
4
Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
J Clin Psychiatry. 2009 Oct;70(10):1379-84. doi: 10.4088/JCP.08m04593. Epub 2009 Jun 30.
5
The APOE ε4 allele is associated with increased frontally mediated neurobehavioral symptoms in amnestic MCI.
Alzheimer Dis Assoc Disord. 2013 Apr-Jun;27(2):109-15. doi: 10.1097/WAD.0b013e318266c6c3.
6
Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.
N Engl J Med. 2009 Jul 16;361(3):255-63. doi: 10.1056/NEJMoa0809437.
7
Low testosterone levels relate to poorer cognitive function in women in an APOE-ε4-dependant manner.
Biol Sex Differ. 2024 Jun 5;15(1):45. doi: 10.1186/s13293-024-00620-4.
9
Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.
Neurology. 2004 Jun 8;62(11):1990-5. doi: 10.1212/01.wnl.0000129533.26544.bf.
10
Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.
JAMA Neurol. 2018 Apr 1;75(4):488-494. doi: 10.1001/jamaneurol.2017.4325.

引用本文的文献

1
Effect of genetic and vascular risk factors on rates of cognitive decline in early-onset and late-onset Alzheimer's disease.
J Alzheimers Dis. 2025 Feb;103(3):920-930. doi: 10.1177/13872877241307321. Epub 2025 Jan 12.
2
4
Effects of obesogenic diet and 17β-estradiol in female mice with 3/3, 3/4, and 4/4 genotypes.
Front Aging Neurosci. 2024 Sep 13;16:1415072. doi: 10.3389/fnagi.2024.1415072. eCollection 2024.
6
Role of light walking pace on cognition: Findings from the Maine-Syracuse Longitudinal Study.
Appl Neuropsychol Adult. 2025 Jul-Aug;32(4):978-992. doi: 10.1080/23279095.2023.2228952. Epub 2023 Jul 4.
8
Vascular Risk Predicts Plasma Amyloid β 42/40 Through Cerebral Amyloid Burden in ε4 Carriers.
Stroke. 2023 May;54(5):1227-1235. doi: 10.1161/STROKEAHA.122.041854. Epub 2023 Apr 6.
10
Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy.
Mol Neurodegener. 2023 Mar 16;18(1):17. doi: 10.1186/s13024-023-00610-x.

本文引用的文献

1
Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.
Cell. 2010 Aug 6;142(3):387-97. doi: 10.1016/j.cell.2010.06.036. Epub 2010 Jul 22.
2
Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.
Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10256-61. doi: 10.1073/pnas.1001412107. Epub 2010 May 17.
3
APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.
Ann Neurol. 2010 Jan;67(1):122-31. doi: 10.1002/ana.21843.
5
Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB.
Neurology. 2010 Mar 9;74(10):807-15. doi: 10.1212/WNL.0b013e3181d3e3e9. Epub 2010 Feb 10.
6
Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.
N Engl J Med. 2009 Jul 16;361(3):255-63. doi: 10.1056/NEJMoa0809437.
8
In vivo mapping of amyloid toxicity in Alzheimer disease.
Neurology. 2009 Apr 28;72(17):1504-11. doi: 10.1212/WNL.0b013e3181a2e896.
9
Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease.
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6820-5. doi: 10.1073/pnas.0900345106. Epub 2009 Apr 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验